InMed Pharmaceuticals Inc. (INM) › Operating IncomeInMed Pharmaceuticals Inc. (INM) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2021: -$10.20M2022: -$18.60M2023: -$7.95M-$7.95M2021Operating Income (USD)2023Fiscal YearOperating IncomeChange YoY2023-$7.95M+57.3%2022-$18.60M-82.3%2021-$10.20M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share